Referências

1. Morens D.M., Fauci A.S., Emerging pandemic diseases: how we got to COVID-19, Cell, 182, 5, pp. 1077-1092, (2020)
2. Infectious Disease Movement in a Borderless World: Workshop Summary. 2. Travel, Conflict, Trade, and Disease, (2010)
3. Schwartz D.A., Bryan R.T., Hughes J.M., Pathology and emerging infections: quo vadimus?, Am J Pathol, 147, pp. 1525-1533, (1995)
4. Bennett J.E., Dolin R., Blaser M.J., Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, (2020)
5. External manifestations of systemic infections., Atlas of infectious diseases, 8, (1997)
6. Gutierrez Y., Diagnostic Pathology of Parasitic Infections with Clinical Correlations, (2000)
7. Connor D.H., Chandler F.W., Manz H.J., Et al., Pathology of Infectious Diseases, (1997)
8. Lucas S.B., Pathology of tropical infections, Oxford Textbook of Pathology, pp. 2187-2266, (1992)
9. Iannetta M., Di Caro A., Nicastri E., Et al., Viral hemorrhagic fevers other than Ebola and Lassa, Infect Dis Clin North Am, 33, pp. 977-1002, (2019)
10. Peters C.J., Zaki S.R., Role of the endothelium in viral hemorrhagic fevers, Crit Care Med, 30, pp. S268-S273, (2002)
11. Ishak K.G., Walker D.H., Coetzer J.A.W., Et al., Viral haemorrhagic fevers with hepatic involvement: pathologic aspects with clinical correlations., Progress in Liver Diseases, VII, pp. 495-515, (1982)
12. Sobel H.J., Wolf E.H., Liver involvement in early syphilis, Arch Pathol Lab Med, 93, pp. 565-568, (1972)
13. Romeu J., Rybak B., Dave P., Et al., Spirochetal vasculitis and bile ductular damage in early hepatic syphilis, Am J Gastroenterol, 74, pp. 352-354, (1980)
14. Judge D.M., Samuel I., Perine P.L., Et al., Louse-born relapsing fever in man, Arch Pathol Lab Med, 97, pp. 136-140, (1974)
15. Shieh W.J., Edwards C., Spiegel R., Leptospirosis, Tropical Infectious Diseases: Principles, Pathogens, and Practice, pp. 547-555, (1999)
16. Alves V.A., Vianna M.R., Yasuda P.H., Et al., Detection of leptospiral antigen in the human liver and kidney using an immunoperoxidase staining procedure, J Pathol, 151, pp. 125-131, (1987)
17. Zaki S.R., Shieh W.J., Leptospirosis associated with an outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua 1995, Lancet, 347, pp. 535-536, (1996)
18. Zaki S.R., Spiegel R.A., Leptospirosis, Pathology of Emerging Infections. II, pp. 73-92, (1998)
19. De Brito T., Menezes L.F., Lima D.M., Et al., Immunohistochemical and in situ hybridization studies of the liver and kidney in human leptospirosis, Virchows Arch, 448, pp. 576-583, (2006)
20. Evangelista K.V., Hahn B., Wunder E.A., Et al., Identification of cell-binding adhesins of Leptospira interrogans , PLoS Negl Trop Dis, 8, (2014)
21. Quaresma J.A., Barros V.L., Fernandes E.R., Et al., Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever, Acta Trop, 94, pp. 116-127, (2005)
22. Heathcote J., Deodhar K.P., Scheuer P.J., Et al., Intrahepatic cholestasis in childhood, N Engl J Med, 295, pp. 801-805, (1976)
23. De Brito T., Silva A.M.G.D., Abreu P.A.E., Pathology and pathogenesis of human leptospirosis: a commented review, Rev Inst Med Trop Sao Paulo, 60, (2018)
24. Pritt B.S., Mead P.S., Johnson D.K., Et al., Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study, Lancet Infect Dis, 16, pp. 556-564, (2016)
25. Goellner M.H., Agger W.A., Burgess J.H., Et al., Hepatitis due to recurrent Lyme disease, Ann Intern Med, 108, pp. 707-708, (1988)
26. Duray P.H., Clinical pathologic correlations of Lyme disease, Rev Infect Dis, 11, pp. S1487-S1493, (1989)
27. Holty J.E., Gould M.K., Meinke L., Et al., Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data, Liver Transpl, 15, pp. 894-906, (2009)
28. Rich A.R., The Pathogenesis of Tuberculosis, (1951)
29. O'Brien J.R., Non-reactive tuberculosis, J Clin Pathol, 7, pp. 216-225, (1954)
30. Siegel M., Pathological findings and pathogenesis of congenital tuberculosis, Am Rev Tuberc, 29, pp. 297-309, (1934)
31. Karat A.B.A., Job C.K., Rao P.S.S., Liver in leprosy: histological and biochemical findings, BMJ, 1, pp. 307-310, (1971)
32. Chen T.S.N., Drutz D.J., Whelan G.E., Hepatic granulomas in leprosy, Arch Pathol Lab Med, 100, pp. 182-185, (1976)
33. Bernstein D.I., Bellamy A.R., Hook E.W., Et al., Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women, Clin Infect Dis, 56, pp. 344-351, (2013)
34. Francis T.I., Moore D.L., Edington G.M., Et al., A clinicopathological study of human yellow fever, Bull WHO, 46, pp. 659-667, (1972)
35. Kramarsky B., Edmondson H.A., Peters R.L., Et al., Lepromatous leprosy in reaction, Arch Pathol Lab Med, 85, pp. 516-531, (1968)
36. Lucas S.B., Mycobacteria and the tissues of man., The Biology of the Mycobacteria, 3, pp. 107-76, (1988)
37. Desikan K.V., Job C.K., A review of post mortem findings in 37 cases of leprosy, Int J Lepr, 36, pp. 32-44, (1968)
38. Singh N., Bhatia A., Lakra A., Et al., Comparative cytomorphology of skin, lymph node, liver and bone marrow in patients with lepromatous leprosy, Cytopathology, 17, pp. 257-261, (2006)
39. Ranawaka R.R., Mendis S., Weerakoon H.S., Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity, Lepr Rev, 79, pp. 436-440, (2008)
40. Han X.Y., Seo Y.H., Sizer K.C., Et al., A new Mycobacterium species causing diffuse lepromatous leprosy, Am J Clin Pathol, 130, pp. 856-864, (2008)
41. Trindade M.A., Palermo M.L., Pagliari C., Et al., Leprosy in transplant recipients: report of a case after liver transplantation and review of the literature, Transpl Infect Dis, 13, pp. 63-69, (2011)
42. MacKay A., Alcorn M.J., MacLeod I.M., Et al., Fatal disseminated BCG infection in an 16-year old boy, Lancet, 2, pp. 1332-1334, (1980)
43. Sohn C.C., Schroff R.W., Kliewer K.E., Et al., Disseminated Mycobacterium avium-intracellulare infection in homosexual men with acquired cell-mediated immunodeficiency: a histological and immunologic study of two cases, Am J Clin Pathol, 79, pp. 247-252, (1983)
44. Whitley R.J., Herpesviruses, Medical Microbiology, (1996)
45. Maasenkeil G., Opravil M., Salfinger M., Et al., Disseminated coinfection with Mycobacterium avium complex and Mycobacterium kansasii in a patient with AIDS and liver abscess, Clin Infect Dis, 14, pp. 618-619, (1992)
46. Duarte-Neto A.N., Cunha M.D.P., Marcilio I., Et al., Yellow fever and orthotopic liver transplantation: new insights from the autopsy room for an old but re-emerging disease, Histopathology, 75, pp. 638-648, (2019)
47. Simor A.E., Patterson C., Disseminated Mycobacterium bovis infection in an elderly patient, Diag Microbiol Infect Dis, 7, pp. 149-153, (1987)
48. Ausina V., Gurgui M., Verger G., Et al., Iatrogenic disseminated Mycobacterium chelonei infection, Tubercle, 65, pp. 53-57, (1984)
49. Dreisin R.B., Scoggin C., Davidson P.T., The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases, Tubercle, 57, pp. 49-57, (1976)
50. Bultmann B.D., Flad H.D., Kaiserling E., Et al., Disseminated mycobacterial histiocytosis due to M. fortuitum associated with helper T-lymphocyte immune deficiency, Virchows Arch, 395, pp. 217-225, (1982)
51. Razon-Veronesi S., Visconti A., Boeri R., Et al., Linfogranulomatosi disseminata da Mycobacterium fortuitum in eta pediatrica, Minerv Pediatr, 35, pp. 775-783, (1983)
52. Martin M., Tsai T.F., Cropp B., Et al., Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases, Lancet, 358, pp. 98-104, (2001)
53. Belsher J.L., Gay P., Brinton M., Et al., Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease, Vaccine, 25, pp. 8480-8485, (2007)
54. Whittembury A., Ramirez G., Hernandez H., Et al., Viscerotropic disease following yellow fever vaccination in Peru, Vaccine, 27, pp. 5974-5981, (2009)
55. James S.H., Kimberlin D.W., Neonatal herpes simplex virus infection: epidemiology and treatment, Clin Perinatol, 42, pp. 47-59, (2015)
56. DeSilva M., Sharma A., Staples E., Et al., Notes from the field: fatal yellow fever vaccine-associated viscerotropic disease—Oregon, September 2014, MMWR, 64, pp. 279-281, (2015)
57. Lindsey N.P., Schroeder B.A., Miller E.R., Et al., Adverse event reports following yellow fever vaccination, Vaccine, 26, pp. 6077-6082, (2008)
58. Monath T.P., Yellow Fever Vaccine, (2004)
59. Barwick Eidex R., Yellow Fever Vaccine Safety Working Group. History of thymoma and yellow fever vaccination, Lancet, 364, (2004)
60. Vasconcelos P.F., Luna E.J., Galler R., Et al., Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases, Lancet, 358, pp. 91-97, (2001)
61. Wahid S.F., Sanusi S., Zawawi M.M., Et al., A comparison of the pattern of liver involvement in dengue haemorrhagic fever with classic dengue fever, Southeast Asian J Trop Med Public Health, 31, pp. 259-263, (2000)
62. Halstead S.B., Dengue, Lancet, 370, pp. 1644-1652, (2007)
63. Ranjit S., Kissoon N., Dengue hemorrhagic fever and shock syndromes, Pediatr Crit Care Med, 12, pp. 90-100, (2011)
64. Bhamarapravati N., Tuchida P., Boonyapaknavik V., Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases, Ann Trop Med Parasit, 61, pp. 500-510, (1967)
65. Huerre M., Lan N.T., Marianneau P., Et al., Liver histopathology and biological correlates in 5 cases of fatal dengue fever in Vietnamese children, Virchows Arch [A], 438, pp. 107-115, (2001)
66. Goodman Z.D., Ishak K.G., Sesterhenn I.A., Herpes simplex hepatitis in apparently immunocompetent adults, Am J Clin Pathol, 85, pp. 694-699, (1986)
67. Gubler D.J., Zaki S.R., Dengue and other viral haemorrhagic fevers, Pathology of Emerging Infections. II, pp. 43-72, (1998)
68. Win M.M., Charngkaew K., Punyadee N., Et al., Ultrastructural features of dengue human liver specimens from patients who died from hemorrhagic fever, Trop Med Infect Dis, 4, (2019)
69. Pfau C.J., Arenaviruses, Medical Microbiology, (1996)
70. Shao J., Liang Y., Ly H., Human hemorrhagic fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis, Pathogens, 4, pp. 283-306, (2015)
71. Edington G.M., White H.A., The pathology of Lassa fever, Trans R Soc Trop Med Hyg, 66, pp. 381-389, (1972)
72. Paweska J.T., Sewlall N.H., Ksiazek T.G., Et al., Outbreak control and investigation teams. Nosocomial outbreak of novel arenavirus infection, southern Africa, Emerg Infect Dis, 15, pp. 1598-1602, (2009)
73. Palacios G., Druce J., Du L., Et al., A new arenavirus in a cluster of fatal transplant-associated diseases, N Engl J Med, 358, pp. 991-998, (2008)
74. Fischer S.A., Graham M.B., Kuehnert M.J., Et al., Transmission of lymphocytic choriomeningitis virus through organ transplantation, N Engl J Med, 354, pp. 2235-2249, (2006)
75. Khan A.S., Tshioko F.K., Heymann D.L., Et al., The reemergence of Ebola haemorrhagic fever, Democratic Republic of Congo, 1995, J Infect Dis, 179, pp. S76-S86, (1999)
76. Okware S.I., Omaswa F.G., Zaramba S., Et al., An outbreak of Ebola in Uganda, Trop Med Int Health, 7, pp. 1068-1075, (2002)
77. Wiegering V., Schick J., Beer M., Et al., Varicella-zoster virus infections in immunocompromised patients: a single centre 6-years analysis, BMC Pediatr, 11, (2011)
78. World Health Organization. Ebola virus haemorrhagic fever, Democratic Republic of the Congo: update, Wkly Epidemiol Rec, 82, pp. 345-346, (2007)
79. Hartman A.L., Towner J.S., ST N., Ebola and Marburg hemorrhagic fever, Clin Lab Med, 30, pp. 161-177, (2010)
80. Bausch D.G., Nichol S.T., Muyembe-Tamfum J.J., Et al., Marburg haemorrhagic fever associated with multiple genetic lineages of virus, N Engl J Med, 355, pp. 909-919, (2006)
81. Towner J.S., Khristova M.L., Sealy T.K., Et al., Marburg virus genomics and associated with a large haemorrhagic fever outbreak in Angola, J Virol, 80, pp. 6497-6516, (2006)
82. Wasswa H., International agencies help fight Marburg disease outbreak in Uganda, BMJ, 349, (2014)
83. Barrette R.W., Metwally S.A., Rowland J.M., Et al., Discovery of swine as a host for the Reston Ebola virus, Science, 325, pp. 204-206, (2009)
84. Leroy E.M., Kumulungui B., Pourrut X., Et al., Fruit bats as reservoirs of Ebola virus, Nature, 438, pp. 575-576, (2005)
85. Towner J.S., Khristova M.L., Sealy T.K., Et al., Marburg virus genomics and associated with a large haemorrhagic fever outbreak in Angola, J Virol, 80, pp. 6497-6516, (2006)
86. Rippey J.J., Schepers N.J., Gear J.H.S., The pathology of Marburg virus disease, S Afr Med J, 66, pp. 50-54, (1984)
87. Zaki S.R., Shieh W.J., Greer P.W., Et al., A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread and surveillance of Ebola haemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit, J Infect Dis, 179, pp. S36-S47, (1999)
88. Kasper W.J., Howe P.M., Fatal varicella after a single course of corticosteroids, Pediatr Infect Dis J, 9, pp. 729-732, (1990)
89. Davis K.J., Anderson A.O., Geisbert T.W., Et al., Pathology of experimental Ebola virus infection in African green monkeys, Arch Pathol Lab Med, 121, pp. 805-819, (1997)
90. Timen A., Koopmans M., Vossen A., Et al., Response to imported case of Marburg haemorrhagic fever, the Netherlands, Emerg Infect Dis, 15, (2009)
91. Imported Lassa fever: New Jersey, 2004, MMWR, 53, pp. 894-897, (2004)
92. Imported case of Marburg haemorrhagic fever: Colorado, 2008, MMWR, 58, pp. 1377-1381, (2009)
93. Martines R.B., Ng D.L., Greer P.W., Et al., Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses, J Pathol, 235, pp. 153-174, (2015)
94. Burt F.J., Swanepoel R., Shieh W.J., Et al., Immunohistochemical and in situ localization of Crimean–Congo haemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis, Arch Pathol Lab Med, 121, pp. 839-846, (1997)
95. Shieh W.J., Paddock C.D., Lederman E., Et al., Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006–2007, Am J Trop Med Hyg, 83, pp. 38-42, (2010)
96. Pallansch M.A., Oberste M.S., Whitton J.L., Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, Fields Virology, pp. 490-530, (2013)
97. Muehlenbachs A., Bhatnagar J., Zaki S.R., Tissue tropism, pathology and pathogenesis of enterovirus infection, J Pathol, 235, 2, pp. 217-228, (2015)
98. Guarner J., Bhatnagar J., Shieh W.J., Et al., Histopathologic, immunohistochemical and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis, Hum Pathol, 38, pp. 1412-1419, (2007)
99. Gatnash A.A., Connolly C.K., Fatal chickenpox pneumonia in an asthmatic patient on oral steroids and methotrexate, Thorax, 50, pp. 422-423, (1995)
100. Robinson M.C., An epidemic of a dengue-like fever in the southern province of Tanganyika, Cent Afr J Med, 2, 11, pp. 394-396, (1956)
101. Weaver S.C., Lecuit M., Chikungunya virus and the global spread of a mosquito-borne disease, N Engl J Med, 372, 13, pp. 1231-1239, (2015)
102. Simon F., Parola P., Grandadam M., Et al., Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands: report of 47 cases, Medicine (Baltimore), 86, 3, pp. 123-137, (2007)
103. Bodenmann P., Genton B., Chikungunya: an epidemic in real time, Lancet, 368, (2006)
104. Javelle E., Gautret P., Simon F., Chikungunya, the emerging migratory rheumatism, Lancet Infect Dis, 15, pp. 509-510, (2015)
105. Hoz J.M., Bayona B., Viloria S., Et al., Fatal cases of Chikungunya virus infection in Colombia: diagnostic and treatment challenges, J Clin Virol, 69, pp. 27-29, (2015)
106. Sharp T.M., Keating M.K., Shieh W.J., Et al., Clinical characteristics, histopathology, and tissue immunolocalization of chikungunya virus antigen in fatal cases, Clin Infect Dis, 2, pp. e345-e354, (2021)
107. Simpson D.I., Zika virus infection in man, Trans R Soc Trop Med Hyg, 58, pp. 335-338, (1964)
108. Fauci A.S., Morens D.M., Zika virus in the Americas—yet another arbovirus threat, N Engl J Med, 374, pp. 601-604, (2016)
109. Martines R.B., Bhatnagar J., Keating M.K., Et al., Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses—Brazil, 2015, MMWR, 65, pp. 159-160, (2016)
110. Abzug M.J., Cotton M.F., Severe chickenpox after intranasal use of corticosteroids, J Pediatr, 123, pp. 577-579, (1993)
111. Zhu N., Zhang D., Wang W., Et al., A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, pp. 727-733, (2020)
112. Wu F., Zhao S., Yu B., Et al., A new coronavirus associated with human respiratory disease in China, Nature, 579, pp. 265-269, (2020)
113. Li W., Shi Z., Yu M., Et al., Bats are natural reservoirs of SARS-like coronaviruses, Science, 310, pp. 676-679, (2005)
114. Hoffmann M., Kleine-Weber H., Schroeder S., Et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 18, pp. 271-280, (2020)
115. Elsoukkary S.S., Mostyka M., Dillard A., Et al., Autopsy findings in 32 patients with COVID-19: a single-institution experience, Pathobiology, 88, 1, pp. 56-68, (2021)
116. Wichmann D., Sperhake J.P., Lutgehetmann M., Et al., Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study, Ann Intern Med, 173, pp. 268-277, (2020)
117. Debes J.D., COVID-19 and the liver: the perils of non-peer-reviewed science in times of a pandemic, Gastroenterology, 159, (2020)
118. Lagana S.M., Kudose S., Iuga A.C., Et al., Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data, Mod Pathol, 33, pp. 2147-2155, (2020)
119. Edler C., Schroder A.S., Aepfelbacher M., Et al., Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany, Int J Legal Med, 134, pp. 1275-1284, (2020)
120. Barton L.M., Duval E.J., Stroberg E., Ghosh S., Mukhopadhyay S., COVID-19 autopsies, Oklahoma, USA, Am J Clin Pathol, 153, pp. 725-733, (2020)
121. Clarke J., Craig R.M., Saffro R., Et al., Cytomegalovirus granulomatous hepatitis, Am J Med, 66, pp. 264-269, (1979)
122. Bussani R., Schneider E., Zentilin L., Et al., Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology, EBioMedicine, 61, (2020)
123. Martines R.B., Ritter J.M., Matkovic E., Et al., Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States, Emerg Infect Dis, 26, 9, pp. 2005-2015, (2020)
124. Vasquez-Bonilla W.O., Orozco R., Argueta V., Et al., A review of the main histopathological findings in coronavirus disease 2019, Hum Pathol, 105, pp. 74-83, (2020)
125. Palaiodimos L., Kokkinidis D.G., Li W., Et al., Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism., 108, (2020)
126. Zheng K.I., Gao F., Wang X.B., Et al., Letter to the editor: obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease, Metabolism, 108, (2020)
127. McMullan L.K., Folk S.M., Kelly A.J., Et al., A new phlebovirus associated with severe febrile illness in Missouri, N Engl J Med, 367, pp. 834-841, (2012)
128. Staples J.E., Pastula D.M., Panella A.J., Et al., Investigation of Heartland virus disease throughout the United States, 2013–2017, Open Forum Infect Dis, 7, 5, (2020)
129. Liu Q., He B., Huang S.Y., Et al., Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis, Lancet Infect Dis, 14, pp. 763-772, (2014)
130. Perry R.T., Murray J.S., Gacic-Dobo M., Et al., Progress toward regional measles elimination—worldwide, 2000–2014, MMWR, 64, pp. 1246-1251, (2015)
131. Phadke V.K., Bednarczyk R.A., Salmon D.A., Et al., Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis, JAMA, 315, pp. 1149-1158, (2016)
132. Zaki S.R., Peters C.J., Et al., Viral haemorrhagic fevers, Pathology of Infectious Diseases, pp. 347-364, (1997)
133. Williams A.O., Autopsy study of measles in Ibadan, Nigeria, Ghana Med J, 9, pp. 23-27, (1970)
134. Scully R.E., Mark E.J., McNeely W.F., Et al., Case records of the Massachusetts General Hospital [measles hepatitis], N Engl J Med, 319, pp. 495-509, (1988)
135. Zaki S.R., Bellini W.J., Et al., Measles, Pathology of Infectious Diseases, pp. 233-244, (1997)
136. McLellan R.K., Gleiner J.A., Acute hepatitis in an adult with rubeola, JAMA, 247, pp. 2000-2001, (1982)
137. Khatib R., Siddique M., Abbass M., Measles associated hepatobiliary disease: an overview, Infection, 21, pp. 112-114, (1993)
138. Snover D.C., Horwitz C.A., Liver disease in cytomegalovirus mononucleosis: a light microscopical and immunoperoxidase study of six cases, Hepatology, 4, pp. 408-412, (1984)
139. Vanstapel M.J., Desmet V.J., Cytomegalovirus hepatitis: a histological and immunohistochemical study, Appl Pathol, 1, pp. 41-49, (1983)
140. Finegold M.J., Carpenter R.J., Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts, Hum Pathol, 13, pp. 662-665, (1982)
141. Purtilo D.T., Sakamoto K., Epstein–Barr virus and human disease: immune response determines the clinical and pathologic expression, Hum Pathol, 12, pp. 677-679, (1981)
142. Schechter S., Lamps L., Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis, Arch Pathol Lab Med, 142, pp. 1191-1195, (2018)
143. Kilpatrick Z.M., Structural and functional abnormalities of liver in infectious mononucleosis, Arch Intern Med, 117, pp. 47-53, (1966)
144. Reynolds D.J., Banks P.M., Gulley M.L., New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin’s disease, Am J Pathol, 146, pp. 379-388, (1995)
145. Louissaint A., Ferry J.A., Soupir C.P., Et al., Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features, Mod Pathol, 25, pp. 1149-1159, (2012)
146. Nenert M., Mavier P., Dubuc N., Et al., Epstein-Barr virus infection and hepatic fibrin-ring granulomas, Hum Pathol, 19, pp. 608-610, (1988)
147. Holborow E.J., Hemsted E.H., Mead S.V., Smooth muscle autoantibodies in infectious mononucleosis, Br Med J, 3, 5875, pp. 323-325, (1973)
148. Paessler S., Walker D.H., Pathogenesis of the viral hemorrhagic fevers, Annu Rev Pathol, 8, pp. 411-440, (2013)
149. Sutton R.N., Emond R.T., Thomas D.B., Doniach D. The occurrence of autoantibodies in infectious mononucleosis, Clin Exp Immunol, 17, pp. 427-436, (1974)
150. Vaughan J.H., Valbracht J.R., Nguyen M.D., Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1, J Clin Invest, 95, pp. 1306-1315, (1995)
151. Randhawa P.S., Jenkins F.J., Nalesnik M.A., Et al., Herpesvirus 6 variant A infection after heart transplantation with giant cell transformation on the bile ductular and gastroduodenal epithelium, Am J Surg Pathol, 21, pp. 847-853, (1997)
152. Carmichael G.P., Zahradnik J.M., Moyer G.H., Et al., Adenovirus hepatitis in an immunosuppressed adult patient, Am J Clin Pathol, 71, pp. 352-355, (1979)
153. Janner D., Petru A.M., Belchis D., Et al., Fatal adenovirus infection in a child with acquired immunodeficiency syndrome, Pediatr Infect Dis J, 9, pp. 434-436, (1990)
154. Krilov L.R., Rubin L.G., Frogel M., Et al., Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states, Rev Infect Dis, 12, pp. 303-307, (1990)
155. Ozawa K., Kurtzman G., Young N., Replication of the B19 parvovirus in the human bone marrow cell cultures, Science, 233, pp. 883-886, (1986)
156. Hatakka A., Klein J., He R., Et al., Acute hepatitis as a manifestation of parvovirus B19 infection, J Clin Microbiol, 49, pp. 3422-3424, (2011)
157. Anand A., Gray E.S., Brown T., Et al., Human parvovirus infection in pregnancy and hydrops fetalis, N Engl J Med, 316, pp. 183-186, (1987)
158. Anderson L., Zaki S.R., Torok T.J., Parvovirus infections (erythema infectiosum), Pediatric Infectious Diseases, (1999)
159. Barnett E.D., Yellow fever: epidemiology and prevention, Clin Infect Dis, 44, pp. 850-856, (2007)
160. Yoto Y., Kudoh T., Haseyama K., Et al., Human parvovirus B19 infection associated with acute hepatitis, Lancet, 347, pp. 868-869, (1996)
161. Langnas A.N., Markin R.S., Cattral M.S., Et al., Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anaemia, Hepatology, 22, pp. 1661-1665, (1995)
162. Srinivasan A., Burton E.C., Kuehnert M.J., Et al., Transmission of rabies virus from an organ donor to four transplant recipients, N Engl J Med, 352, pp. 1103-1111, (2005)
163. Zhang J., Lin J., Tian Y., Et al., Transmission of rabies through solid organ transplantation: a notable problem in China, BMC Infect Dis, 18, (2018)
164. Pellegrin M., Delsol G., Auvergant J.C., Et al., Granulomatous hepatitis in Q fever, Hum Pathol, 11, pp. 51-57, (1980)
165. Lobdell D.H., ‘Ring’ granulomas in cytomegaloviral hepatitis, Arch Pathol Lab Med, 111, pp. 881-882, (1987)
166. Murphy E., Griffiths M.R., Hunter J.A., Et al., Fibrin-ring granulomas: a non-specific reaction to liver injury?, Histopathology, 19, pp. 91-93, (1991)
167. Rovery C., Brouqui P., Raoult D., Questions on Mediterranean spotted fever a century after its discovery, Emerg Infect Dis, 14, pp. 1360-1367, (2008)
168. De Sousa R., Nobrega S.D., Bacellar F., Et al., Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients, Ann NY Acad Sci, 990, pp. 285-294, (2003)
169. Guardia J., Martinez-Vazquez J.M., Moragas A., The liver in boutonneuse fever, Gut, 15, pp. 549-551, (1974)
170. Monath T.P., Vasconcelos P.F., Yellow fever, J Clin Virol, 64, pp. 160-173, (2015)
171. Walker D.H., Staiti A., Mansueto G., Et al., Frequent occurrence of hepatic lesions in boutonneuse fever, Acta Trop, 43, pp. 175-181, (1986)
172. Adams J.S., Walker D.H., The liver in Rocky Mountain spotted fever, Am J Clin Pathol, 75, pp. 156-161, (1981)
173. Jackson M.D., Kirkman C., Bradford W.D., Et al., Rocky Mountain spotted fever: hepatic lesions in childhood cases, Pediatr Pathol, 5, pp. 379-388, (1986)
174. Paddock C.D., Greer P.W., Ferebee T., Et al., Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease, J Infect Dis, 179, pp. 1469-1476, (1999)
175. Hong D.G., Choi M.H., Chong G.O., Et al., Fitz-Hugh-Curtis syndrome: single centre experiences, J Obstet Gynaecol, 30, pp. 277-280, (2010)
176. Sehdev A.E., Dumler J.S., Hepatic pathology in human monocytic ehrlichiosis: Ehrlichia chaffeensis infection, Am J Clin Pathol, 119, pp. 859-865, (2003)
177. Dawson J.E., Paddock C.D., Warner C.K., Et al., Tissue diagnosis of Ehrlichia chaffeensis in patients with fatal ehrlichiosis by use of immunohistochemistry, in situ hybridization and polymerase chain reaction, Am J Trop Med Hyg, 65, pp. 603-609, (2001)
178. Rackow E.C., Astiz M.E., Pathophysiology and treatment of septic shock, JAMA, 266, pp. 548-554, (1991)
179. Bagshawe A., Miller J.R.M., The aetiology of portal hypertension associated with gross haemorrhage in Kenya, East Afr Med J, 47, pp. 185-187, (1970)
180. Nakhleh R.E., Glock M., Snover D.C., Hepatic pathology of chronic granulomatous disease in childhood, Arch Pathol Lab Med, 116, pp. 71-75, (1992)
181. Douam F., Ploss A., Yellow fever virus: knowledge gaps impeding the fight against an old foe, Trends Microbiol, 26, pp. 913-928, (2018)
182. Woo S.Y., Kim J.I., Cheung D.Y., Et al., Clinical outcome of Fitz-Hugh-Curtis syndrome mimicking acute biliary disease, World J Gastroenterol, 14, pp. 6975-6980, (2008)
183. Risser W.L., Risser J.M., Benjamins L.J., Et al., Incidence of Fitz-Hugh-Curtis syndrome in adolescents who have pelvic inflammatory disease, J Pediatr Adolesc Gynecol, 20, pp. 179-180, (2007)
184. Butler T., Plague and other Yersinia infections, (1983)
185. Guarner J., Shieh W.J., Greer P.W., Et al., Immunohistochemical detection of Yersinia pestis in formalin-fixed paraffin-embedded tissue, Am J Clin Pathol, 117, pp. 205-209, (2002)
186. Stjernberg U., Silseth C., Rifland S., Granulomatous hepatitis in Yersinia enterocolitica infection, Hepatogastroenterology, 34, pp. 56-57, (1987)
187. Guarner J., Greer P.W., Bartlett J., Et al., Immunohistochemical detection of Francisella tularensis in formalin-fixed paraffin-embedded tissue, Appl Immunohistochem Mol Morph, 7, pp. 122-126, (1999)
188. Guarner J., Jerningan J.A., Shieh W.J., Et al., Anthrax Pathology Working Group. Pathology and pathogenesis of bioterrorism-related inhalational anthrax, Am J Pathol, 163, pp. 701-709, (2003)
189. Tatti K.M., Greer P.W., White E., Et al., Morphological, immunological and molecular methods to detect B. anthracis in formalin-fixed tissues, Appl Immunohistochem Mol Morph, 14, pp. 234-243, (2006)
190. Elliott S.P., Rat bite fever and Streptobacillus moniliformis , Clin Microbiol Rev, 20, pp. 13-22, (2007)
191. Oehler R.L., Velez A.P., Mizrachi M., Et al., Bite-related and septic syndromes caused by cats and dogs, Lancet Infect Dis, 9, pp. 439-447, (2009)
192. Casadio L., Nastri A.C., Malta F.M., Et al., Late-onset relapsing hepatitis associated with Yellow Fever, N Engl J Med, 382, pp. 2059-2061, (2020)
193. Greenstein A.J., Lowenthal B.A., Hammer G.F.S., Et al., Continuing patterns of disease in pyogenic liver abscess: a study of 38 cases, Am J Gastroenterol, 79, pp. 217-226, (1984)
194. Akritidis N., Tzivras M., Delladetsima I., Et al., The liver in brucellosis, Clin Gastroenterol Hepatol, 5, pp. 1109-1112, (2007)
195. Young E.J., Hasanjani Roushan M.R., Shafae S., Et al., Liver histology of acute brucellosis caused by Brucella melitensis , Hum Pathol, 45, pp. 2023-2028, (2014)
196. Cervantes F., Carbonell J., Bruguera M., Et al., Liver disease in brucellosis: a clinical and pathologic study of 40 cases, Postgrad Med J, 58, pp. 346-350, (1982)
197. Christou L.G., Dalekos G.N., Barbati K., Et al., A 54-year old stockbreeder with ascites, Lancet, 349, (1997)
198. Dance D.A., Melioidosis as an emerging global problem, Acta Trop, 74, pp. 115-119, (2000)
199. Wiersinga W.J., Currie B.J., Peacock S.J., Melioidosis, N Engl J Med, 367, pp. 1035-1044, (2012)
200. Piggot J.A., Hochholzer L., Human melioidosis: a histopathologic study of acute and chronic melioidosis, Arch Pathol Lab Med, 90, pp. 101-111, (1970)
201. Yu V.L., Miller W.P., Wing E.J., Et al., Disseminated listeriosis presenting as acute hepatitis, Am J Med, 73, pp. 773-777, (1982)
202. Elchert J.A., Mansoor E., Abou-Saleh M., Et al., Epidemiology of Whipple’s disease in the USA between 2012 and 2017: a population-based national study, Dig Dis Sci, 64, pp. 1305-1311, (2019)
203. Klotz O., Belt T.H., The pathology of the liver in yellow fiver, Am J Pathol, 6, pp. 663-688, (1930)
204. von Herbay A., Otto H.F., Stolte M., Epidemiology of Whipple’s disease in Germany. Analysis of 110 patients diagnosed in 1965-95, Scand J Gastroenterol, 32, pp. 52-57, (1997)
205. Muir-Padilla J., Myers J.B., Whipple disease: a case report and review of the literature, Arch Pathol Lab Med, 129, pp. 933-936, (2005)
206. Fenollar F., Puechal X., Raoult D., Whipple’s disease, N Engl J Med, 356, pp. 55-66, (2007)
207. Spach D.H., Koehler J.E., Bartonella-associated infections, Infect Dis Clin North Am, 12, pp. 137-155, (1998)
208. Rizkallah M.F., Meyer L., Ayoub E.M., Hepatic and splenic abscesses in cat-scratch disease, Pediatr Infect Dis J, 7, pp. 191-195, (1988)
209. Delbeke D., Sandler M.P., Shaff M.I., Et al., Cat-scratch disease: report of a case with liver lesions and no lymphadenopathy, J Nucl Med, 29, pp. 1454-1456, (1988)
210. Ahsan N., Holman M.J., Riley T.R., Et al., Peliosis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-renal syndrome, Transplant, 65, pp. 1003-1007, (1998)
211. Putman H.C., Dockerty M.B., Waugh J.M., Abdominal actinomycosis: an analysis of 122 cases, Surgery, 28, pp. 781-790, (1993)
212. Kazmi K.A., Rab S.M., Primary hepatic actinomycosis: a diagnostic problem, Am J Trop Med Hyg, 40, pp. 310-311, (1989)
213. Chandler F.W., Kaplan W., Ajello L., A Color Atlas and Text of the Histopathology of Mycotic Diseases, (1980)
214. Quaresma J.A., Barros V.L., Pagliari C., Et al., Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity, Virology, 345, pp. 22-30, (2006)
215. Brooks S.E.H., Audretsch J.J., Hepatic ultrastructure in congenital syphilis, Arch Pathol Lab Med, 102, pp. 502-505, (1978)